Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Ardelyx, Inc. - Common Stock
(NQ:
ARDX
)
6.870
-0.140 (-2.00%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Ardelyx, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
January 08, 2024
Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on...
Via
Benzinga
What's Going On With Ardelyx Stock?
↗
January 08, 2024
Ardelyx, Inc. (NASDAQ: ARDX) shares are trading higher Monday after the company provided a strategic business update.
Via
Benzinga
Positive News For Skin Health: Aldeyra Therapeutics' ADX-629 Achieves Key Milestones in Atopic Dermatitis Study
↗
December 19, 2023
Aldeyra Therapeutics Inc (NASDAQ: ALDX) released topline results from a Phase 2 clinical trial of ADX-629, an investigational RASP modulator, in
Via
Benzinga
The Latest Analyst Ratings for Ardelyx
↗
December 01, 2023
Via
Benzinga
Why Ardelyx Stock Soared Today
↗
October 31, 2023
Ardelyx delivered a strong quarter thanks to solid demand for its first FDA-approved product. Here's what investors need to know.
Via
The Motley Fool
Why Shares of Ardelyx Were Down Wednesday
↗
October 11, 2023
The company's hopes for approval of a drug to treat chronic kidney disease took a hit.
Via
The Motley Fool
Patient Demand Drives Ardelyx's Constipation Drug Success Amid IBS-C Treatment Gap, Says Analyst
↗
December 18, 2023
Raymond James initiated coverage of Ardelyx Inc (NASDAQ: ARDX), noting the company's two early-stage launches underway for the same molecule with differentiated pricing:
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
December 14, 2023
Via
Benzinga
3 Short-Squeeze Stocks Ready for a Year-End Rally
↗
December 14, 2023
These are a few companies that have seen considerable gains this year that still have a large percentage of short interest.
Via
InvestorPlace
7 Penny Stocks You’ll Regret Not Buying Soon: November 2023
↗
November 21, 2023
Unlock robust upside potential by wagering on these top penny stocks to buy in a volatile market at this time.
Via
InvestorPlace
5 OTC Stocks With The Potential To Explode In 2024
↗
November 08, 2023
Investors who are ready to dive into the OTC pool have more options than ever, both with the number of stocks to choose from and available investing platforms.
Via
Benzinga
Analyst Expectations for Ardelyx's Future
↗
September 12, 2023
Via
Benzinga
Arista Networks, JinkoSolar, Repligen, Shutterstock And Other Big Stocks Moving Higher On Tuesday
↗
October 31, 2023
U.S. stocks traded lower, with the Dow Jones falling more than 50 points on Tuesday. Here are some major stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
3 Penny Stocks to Buy and Hold for the Next 10 Years
↗
October 29, 2023
These three penny stocks are the ones to buy and hold through the market conditions and the years to come for returns.
Via
InvestorPlace
Tesla, Nokia And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
↗
October 19, 2023
U.S. stock futures traded lower this morning on Thursday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Why Ardelyx Stock Popped Today
↗
October 18, 2023
Ardelyx finally received the long-awaited FDA approval for its chronic kidney disease drug.
Via
The Motley Fool
Crude Oil Rises Sharply; Ardelyx Shares Spike Higher
↗
October 18, 2023
U.S. stocks traded lower toward the end of trading, with the S&P 500 falling more than 1% on Wednesday. The Dow traded down 0.70% to 33,760.26 while the NASDAQ fell 1.45% to 13,338.71. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Why Nuvve Holding Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
October 18, 2023
Gainers Shift Technologies, Inc. (NASDAQ: SFT) shares climbed 107.8% to $0.2239. Shift Technologies recently said it will file for Chapter 11 bankruptcy protection.
Via
Benzinga
Topics
Bankruptcy
Abbott Laboratories, Nasdaq, Spirit AeroSystems And Other Big Stocks Moving Higher On Wednesday
↗
October 18, 2023
U.S. stocks traded lower, with the Dow Jones falling around 50 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Workhorse (WKHS) Stock Jumps on Drone Business Success
↗
October 18, 2023
Workhorse stock is getting a boost on Wednesday morning after providing WKHS investors with an update on its drone business.
Via
InvestorPlace
FDA Sends ARDX Stock Soaring After Approving Ardelyx’s Kidney Disease Drug
↗
October 18, 2023
ARDX stock is rallying after the U.S. Food and Drug Administration (FDA) approved Ardelyx's kidney disease treatment.
Via
InvestorPlace
After Initial Rejection, FDA Approves Ardelyx's Kidney Disease-Related Drug
↗
October 18, 2023
The FDA approved Ardelyx Inc's (NASDAQ: ARDX) Xphozah (tenapanor), the first and only phosphate absorption inhibitor, indicated to reduce serum phosphorus in adults with chronic kidney disease (CKD) on...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
October 17, 2023
It's time for another dive into the biggest pre-market stock movers as we list out the top stocks worth watching on Tuesday!
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
↗
October 11, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
October 09, 2023
Via
Benzinga
Jim Cramer Likes This Oil Giant Up Almost 28% In A Year — 'It Has Room To Grow'
↗
October 02, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Caterpillar Inc. (NYSE: CAT).
Via
Benzinga
The 3 Best Penny Stocks to Buy Now: September 2023
↗
September 12, 2023
When all the focus lies on the largest names of the economy, these best penny stocks to buy offer a great risk/reward ratio.
Via
InvestorPlace
Topics
Economy
The 3 Most Promising Penny Stocks to Own Now
↗
August 30, 2023
Explore top penny stock picks, not just whims but for powerhouses poised for exponential growth over the long term.
Via
InvestorPlace
3 Penny Stocks You’ll Regret Not Buying Soon
↗
August 26, 2023
There are plenty of penny stocks to buy, but not all of them are created equal. Here are some of the best options to choose from.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023
↗
September 07, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today